Introduction
Sarcoidosis, an multisystemic disease, may affect the entire visual apparatus and its adnexa. The eyes are affected only in one fourth of cases and majority of the lesions are asysmptomatic, requiring appropriate examination technique to be detected.1 Sarcoidosis is a systemic chronic granulomatous disease of unknown aetiology characterised by non-caseating granulomatous inflammation of various organs with protean clinical manifestation. Sarcoidosis commonly involves the eye causing uveitis, lacrimal gland and cranial nerves including the optic nerve itself.
Case Report
We present a case of Sarcoidosis outside the lungs presenting as lacrimal gland with swelling on right eye since 2 months. Pt XY Male Age 55 years coming from Gujarat (Fig. 1).
H/O Diabetes mellitus since 4 years.
H/O Essential Hypertension since 10 years.
 |
| Fig. 1 :Showing lacrimal gland swelling. |
H/O Dryness of effected Eye.
No H/O fever, Arthalgia, dermatology lesion, Anorexia neurological deficit, fungal, viral, Chlamydia infection.
Cardiovascular and Respiratory status normal.
| O/E |
Right Eye |
| Vision |
6/6/ |
| Lid |
Normal |
| Conjunctiva |
Normal |
| Fundus |
Normal |
| Sclera |
Normal |
Lacrimal Glands swelling 1 x 1.5 cms.
Shirmer's Test : 10 mm
Tear film break up time : 10 secs.
Rose Bengal staining of conjunctiva : Negative
Occular Movements : Normal.
Investigation
- X-ray chest normal.
-
| CBC |
Hb 14.8 gms/dl, RBC 5.03 mill/cu.mm |
| |
WBC 8,300/cu.mm N65 E02 L33. |
| |
PCV 49 MCV 86.2 MCH 28.3 MCHC 29.4 |
| |
Platelet 2.74 lacs/cu.mm. |
- ESR 70 mm at the end of one hour (Western gren)
- Angiotensin Converting Enzyme (ACE) : - 70 U/ml.
Method ELISA (N.R. - 0-52 U/ml).
- Fasting Blood Sugar 126 mg%, Post prandial blood sugar 220 mg%,
- HBA1C 8.3%.
- M.R.I. Scan : - revealed swelling of lacrimal gland measuring 2 x 3 cms (Fig. 2).
- Biopsy of mass of right eye revealed noncaseating granuloma suggestive of Sarcoidosis (Fig. 3).
Treatment with prednisolone 40 mg daily for one month the lesion resolved completely.
Discussion
Familial Sarcoidosis is rare.2 It is unusual for lacrimal gland enlargement to be the initial manifestation of sarcoidosis. Sarcoidosis is a multisystemic inflammatory disease of unknown aetiology that predominantly affects the lungs and intrathoracic lymph nodes. Since there is no possible infectious aetiology evident so far, importance of autoimmune process being involved in the pathogenesis of sarcoid should be considered
 |
 |
| Fig. 1 :Showing lacrimal gland swelling. |
Fig. 3 :H and E section showing biopsy of mass of right eye revealing noncaseating granuloma suggestive of sarcoidosis. |
because there is an accumulation of CD4 cells at the site of disease activity which is manifested clinically by an inverted CD4/CD8 ratio. There is increased production of TH1 cytokines such as interferon. TNF, the importance of these cytokines in propagating inflammation is demonstrated by Anti TNF agent such as pentoxifylline and infliximab.3-5 There is increase in fibrinogenic cytokines for e.g.:- transforming growth factor beta (TGF beta) around the sarcoid lesion. The patients serological test failed to demonstrate the presence of rheumatoid factor, antinuclear and anti ds DNA antibodies. No cryglobulins were detected. There was regression of clinical signs after treatment with glucocorticoid even though the patient was diabetic which was controlled by human insulin injection Actaprid Monotard. Metabolic monitoring was done by estimation of Glycoslyated Haemoglobin (GHbA1c). Since the patient was an diabetic his immune response is sluggish ie the subsets of Thelper cells for e.g.. TH1 and TH2. TH1 cells normally boost cell mediated immunity. TH2 cells seem more important in generation of secretory immune response in the mucosa.6,7 The TH2 cells in diabetes are virtually absent which may account for the pathogenesis of sarcoidosis. T cells play a central role in the development of sarcoidosis as they likely propagate an excessive cellular immune response. There is an accumulation of CD4 cells accompanied by the release of interleukin (IL)-2 at the site of disease activity. This may be manifested clinically by an inverted CD4/CD8 ratio Study of Bronchoalveolar lavage (BAL) in occular sarcoidosis may be of value in refractory cases where the diagnosis is doubtful. In such cases BAL will have lymphocytosis with predominant T4+ helper cells.8,9 Tear specific protein would also help in refractory cases of occular sarcoidosis.10
Even though our patient was showing normal X-ray chest but still Gallium 67 citrate scan would reveal the chronic course of the disease or regression of the lymph node. However gallium scanning is a sensitive method in localising chronic occular affective in cases in which the lung changes are no longer detectable.11-13
The literature also mentions a new method in evaluating the anatomy and patency of the lacrimal drainage. Thermography is found to be safe simple technique.14 We had even evaluated the biopsy sample for mycobacterial tuberculosis, but negative because initially it was thought that the mycobacterial antigen plays a role in granuloma formation with sarcoidosis.15
Evaluating the diagnostic and therapeutic procedure can be difficult because there are no standard guidelines. A vital threat, demands rapid diagnosis and effective therapeutic evaluation of the appropriate therapy especially in systemic disease associated with sarcoidosis.16
However in diabetes with sarcoid systemic steroid could be avoided since the immune response being sluggish systemically so in such cases local steroid injection or surgical excision of the affected areas may be useful in selected patients.17
References
- Angi MR, Cipriani A, et al. Asymptomatic occular Sarcoidosis. Sarcoidosis 1985; 2 (2) : 124-34.
- Nowriski T, Flanagan J, et al. Lacrimal gland enlargement in familial sarcoidosis. Opthalmology 1983; 90 (8) : 909-13.
- Yee AM, Pochapin MB. Treatment of complicated sarcoidosis with infliximab, antitumour necrosis factor alpha therapy. Ann Intern Med 2001; 135 (1) : 27.31 (Medline)
- Zabel P, Entzian P, et al. Pentoxifylline treatment of sarcoidosis. Am J Resp Crit Care Med 1997; 155 (5) : 1665-9 (Medline).
- Kataria YP, Holter JF. Immunology of sarcoidosis. Clin Chest Med 1997; 18 : 719-40 (Medline).
- Fuachere SL, et al. Immunological aspect etc current opinion. Gastroenterology 1995; 11 :
12-34.
- Shumoyam T, Crabrea B. Bacterial factors and immune pathogenesis in H pylori infection. Gut 1998; 43 Supplement 1: 52-55.
- Bienfait ME, Hoogsteden HC, et al. Diagnostic value of brochoalveolar lavage in occular sarcoidosis. Acta Ophthal Mol (open h) 1987; 65 (6) : 745-8.
- Ziora D, Oklek K. Brochoalveolar Lavage. BAL in pulm sarcoidosis II. Changes in BAL, cellular morphology and respiratory function in patients with sarcoidosis treated with Predinisone. Pneumonal Alergol Pol 1993; 61 (3-4) : 159-65.
- Inada K, Baba H, et al. Studies of human tear proteins : 4 Analysis by crossed immunoelectrophoresis of tears in various diseases. Jpn J Opthalmol 1965; 29 (2) : 212-21.
- Karma A, Pouk Kula A, et al. Gallium 67 ciyrate scanning in patients with lacrimal gland and conjunctival sarcoidosis. A report of 3 cases. Acta Ophthalmol (Copenh) 1984; 62 (4) : 549-55.
- Sulavik SB, Palestro CJ, et al. Extrapulmonary sites of radiogallium accumulation in sarcoidosis. Clini Nucl Med 1990; 15 (12) : 876-8.
- Yanardog H, Pamuk ON. Lacrimal gland involvement in sarcoidosis. The clinical features of 9 patients. Swiss Med Wkly 2003; 133 (27-28) : 388-91.
- Raflo GT, Chart P, et al. Theramographic evaluation of the human Lacrimal drainage system. Ophthalmlic Surg 1982; 13 (2) : 119-24.
- Banfioli AA, Orefice F. Semin Ophthalmol 2005; 20 (3) : 177-82.
- Place T1 Stev C. Sarcoidosis acute versus chronic - 2 case reports. Scheiz. Rundsch Med Prax 2000; 89 (3) : 79-85.
- Bower JS, Belen JE, Weg JG. Manifestations and treatment of laryngeal sarcoidosis. Am Rev Respiratory Disease 1980; 122 (2) : 325-32.
COMBINING ASPIRIN WITH ANTITHROMBOTIC AGENTS
With the development of safer antiplatelet agents such as thienopyridines and the publication of major randomised studies, the combination of aspirin and clopidogrel has become a class I recommendation that is, it is considered to be beneficial, useful, and effective after percutaneous coronary interventions with stenting in the US and in Europe. Combined antithrombotic therapy is recommended for up to 12 months “in patients who are not at high risk of bleeding. The problem for clinicians is to balance the benefits of combined antiplatelet therapy with the potentially increased risk of gastrointestinal bleeding.
It has been shown repeatedly that combining aspirin with clopidogrel increases the risk of gastrointestinal bleeding compared with using aspirin or clopidogrel alone.
Hallas and colleagues found that upper gastro-intestinal bleeding was associated with the use of low dose aspirin, dipyridamole, and vitamin K antagonists but not with clopidogrel.
In addition to these strategies, combined anti-thrombotic therapy should be given for the shortest duration possible to minimise the risk of bleeding.
Joseph J Y Sung, BMJ, 2006; 333 : 712-13.
*Occular Pathologist,***Ophthalmologist, Akshar Eye Clinic. **HOD and Professor of Pathology; ****Professor of Pathology, CMPH Medical College, Vile Parle (W), Mumbai.
|